UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058441
Receipt number R000066822
Scientific Title Optimal timing for parental nutrition and delivery route of adequate protein in critical care trial
Date of disclosure of the study information 2025/07/12
Last modified on 2025/07/15 10:37:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Optimal timing for parental nutrition and delivery route of adequate protein in critical care trial

Acronym

PANDRA trial

Scientific Title

Optimal timing for parental nutrition and delivery route of adequate protein in critical care trial

Scientific Title:Acronym

PANDRA trial

Region

Japan


Condition

Condition

Critically ill patients

Classification by specialty

Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to elucidate 1)optimal delivery route for adequate protein in early enteral nutrition and 2)optial timing for parental nutrition when early enteral nutrition is not possible, in critically ill patients.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase



Assessment

Primary outcomes

Abilities to perform basic activities of daily living (Barthel Index) at 90 days after randomization

Key secondary outcomes

28-day and 90-day mortality after randomization
Quality of life (EQ-5D-5L) at 90 days after randomization
Hospital-, ICU-, Ventilator-, RRT-free days up to 90 days after randomization
Infectious diseases up to 28 days after randomization
Muscle volume at 7 days and 28 days (or at discharge) after randomization, and changes in muscle volume from randomization to 7 days and 28 days (or at discharge) after randomization
Changes in abilities to perform basic activities of daily living (Barthel Index) from the initiation of intensive care to 90 days after randomization
Severe adverse events up to 90 days after randomization


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration


Blocking

YES

Concealment

Central registration


Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

(When early enteral nutrition within 48 h after enrollment is possible)
Protein is administered only through the enteral route

Interventions/Control_2

(When early enteral nutrition within 48 h after enrollment is possible)
Protein is administered both through the enteral route and parental (intravenous) route

Interventions/Control_3

(When early enteral nutrition within 48 h after enrollment is not possible)
Parental (intravenous) nutrition is initiated within 60 h after enrollment

Interventions/Control_4

(When early enteral nutrition within 48 h after enrollment is not possible)
Parental (intravenous) nutrition is not initiated until at least 96 h after enrollment

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

18 years old or older
Requiring intensive care
Oral intake nutrition is not possible

Key exclusion criteria

Enteral nutirion has been initiated before enrollment
Withholding or withdrawing of care before enrollment
Consent to participate in the trial cannot be obtained
Ineligible to participate determined by a clinical physician

Target sample size

720


Research contact person

Name of lead principal investigator

1st name Ryo
Middle name
Last name Yamamoto

Organization

Keio University School of Medicine

Division name

Department of Emergency and Critical Care Medicine

Zip code

1608582

Address

35 Shinanomachi, Shinjuku, Tokyo

TEL

0332251323

Email

ryoyamamoto@keio.jp


Public contact

Name of contact person

1st name Ryo
Middle name
Last name Yamamoto

Organization

Keio University School of Medicine

Division name

Department of Emergency and Critical Care Medicine

Zip code

1608582

Address

35 Shinanomachi, Shinjuku, Tokyo

TEL

0332251323

Homepage URL


Email

ryoyamamoto@keio.jp


Sponsor or person

Institute

Keio University

Institute

Department

Personal name

Ryo Yamamoto


Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)

Japanese Society of Intensive Care Medicine


IRB Contact (For public release)

Organization

Keio University School of Medicine, Institutional Review Board

Address

35 Shinanomachi, Shinjuku, Tokyo

Tel

03-3353-1211

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW

東京都


Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 07 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 07 Month 01 Day

Date of IRB

2025 Year 07 Month 10 Day

Anticipated trial start date

2025 Year 08 Month 01 Day

Last follow-up date

2027 Year 10 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 07 Month 12 Day

Last modified on

2025 Year 07 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066822